从良性到恶性：垂体神经内分泌肿瘤 (PitNET) 的到来。

Q3 Medicine

Journal of insurance medicine (New York, N.Y.) Pub Date : 2023-07-01 DOI:10.17849/insm-50-2-154-156.1

Timothy Meagher

{"title":"从良性到恶性：垂体神经内分泌肿瘤 (PitNET) 的到来。","authors":"Timothy Meagher","doi":"10.17849/insm-50-2-154-156.1","DOIUrl":null,"url":null,"abstract":"Pituitary adenomas were recently reclassified as \"neuroendocrine tumors,\" and are now considered to be cancers. The evolution and justification for this change are described. Critical illness policies, which currently provide coverage of pituitary adenomas under the \"Benign Brain Tumor\" provision must now be modified to reflect this new taxonomy. This change also prompts questions about the use of the words 'benign' and 'tumor' in critical illness policies.","PeriodicalId":39345,"journal":{"name":"Journal of insurance medicine (New York, N.Y.)","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"From Benign to Malignant: The Arrival of Pituitary Neuroendocrine Tumors (PitNETs).\",\"authors\":\"Timothy Meagher\",\"doi\":\"10.17849/insm-50-2-154-156.1\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Pituitary adenomas were recently reclassified as \\\"neuroendocrine tumors,\\\" and are now considered to be cancers. The evolution and justification for this change are described. Critical illness policies, which currently provide coverage of pituitary adenomas under the \\\"Benign Brain Tumor\\\" provision must now be modified to reflect this new taxonomy. This change also prompts questions about the use of the words 'benign' and 'tumor' in critical illness policies.\",\"PeriodicalId\":39345,\"journal\":{\"name\":\"Journal of insurance medicine (New York, N.Y.)\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of insurance medicine (New York, N.Y.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.17849/insm-50-2-154-156.1\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of insurance medicine (New York, N.Y.)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.17849/insm-50-2-154-156.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

摘要

垂体腺瘤最近被重新归类为 "神经内分泌肿瘤"，现在被认为是癌症。本文介绍了这一变化的演变过程和理由。目前在 "良性脑肿瘤 "条款下承保垂体腺瘤的重大疾病保单现在必须进行修改，以反映这一新的分类。这一变化也引发了关于重大疾病保险中 "良性 "和 "肿瘤 "这两个词的使用问题。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

From Benign to Malignant: The Arrival of Pituitary Neuroendocrine Tumors (PitNETs).

Pituitary adenomas were recently reclassified as "neuroendocrine tumors," and are now considered to be cancers. The evolution and justification for this change are described. Critical illness policies, which currently provide coverage of pituitary adenomas under the "Benign Brain Tumor" provision must now be modified to reflect this new taxonomy. This change also prompts questions about the use of the words 'benign' and 'tumor' in critical illness policies.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of insurance medicine (New York, N.Y.) Medicine-Medicine (all)

CiteScore

0.50

自引率

0.00%

发文量

期刊介绍： The Journal of Insurance Medicine is a peer reviewed scientific journal sponsored by the American Academy of Insurance Medicine, and is published quarterly. Subscriptions to the Journal of Insurance Medicine are included in your AAIM membership.